They do orphan drug designation which wouldn't qualify as lyrica is available. They do IND (investigational new drug) which i think would. Both still require trials but their exclusivity period lengthens and greater access is granted to the panel.
From my memory and limited understanding.
I'd love to hold this overnight, will open at $5 if no cr
Ann: Zeliras diabetic nerve pain drug outperforms Lyrica, page-64
-
- There are more pages in this discussion • 154 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ZLD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
80.0¢ |
Change
0.005(0.63%) |
Mkt cap ! $9.077M | |||
| Open | High | Low | Value | Volume |
| 80.0¢ | 80.0¢ | 80.0¢ | $2.442K | 3.052K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7894 | 76.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 80.0¢ | 7243 | 1 |
View Market Depth
| Last trade - 13.20pm 09/08/2024 (20 minute delay) ? |
| ZLD (ASX) Chart |